404
+1-313-307-4176
Chemiluminescence Immunoassay (CLIA) Analyzers Market Report
Chemiluminescence Immunoassay (CLIA) Analyzers Market Trends, Dynamics & Market Insights
Chemiluminescence Immunoassay (CLIA) Analyzers Market, By Type (High Throughput, Medium Throughput, Low Throughput), Product (Reagents, Consumables, Analyzers), Application (Oncology & Endocrinology, Hepatitis, and Retroviruses, Cardiac Markers, Bone and Mineral Disorders, Auto-Immune Diseases, Others), End-User (Hospitals & Clinics, Pharmaceutical Companies, Medical & Diagnostic Laboratories s) and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Chemiluminescence Immunoassay (CLIA) Analyzers market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The Chemiluminescence Immunoassay (CLIA) Analyzers Market is expected to grow from USD 5.2 billion in 2020 to USD 7.2 billion by 2026 at a CAGR of over 5.8% during the forecast period.
Chemiluminescence is defined as the emission of light during a chemical reaction that does not produce significant qualities of heat. Chemiluminescence immunoassay (CLIA) analyzers are defined as light detectors devices that are particularly developed to measure the antigen-antibody complex formation using the emission of light.
Key players operating in the Chemiluminescence Immunoassay (CLIA) Analyzers Market are-
The growth of the Chemiluminescence Immunoassay (CLIA) Analyzers market is primarily driven by widespread use in numerous applications including oncology & endocrinology, hepatitis and retroviruses, cardiac markers, bone and mineral disorders, auto-immune diseases, and others. The increasing prevalence of chronic diseases due to changing lifestyles and unhealthy eating habits is likely to drive the market growth at a significant rate during the review period. Additionally, the surging demand for advanced immunoassay analyzers is likely to create lucrative opportunities for the players operating in the global market in the coming years.
Based on end-user, the market has been segmented into hospitals & clinics, pharmaceutical companies, and medical & diagnostic laboratories. The hospitals & clinics segment accounted for the largest market share in 2020 and is projected to register significant CAGR during the review period. The segment growth can be attributed to the presence of established healthcare infrastructure and skilled staff.
Geographically, the market in North America accounted for the largest market share in 2020 and is expected to register significant CAGR during the review period. The market growth can be attributed to the high demand for advanced chemiluminescence immunoassay analyzers and the presence of key market players such as Abbott Laboratories (US) and Johnson & Johnson (US). The market in Asia-Pacific is expected to be driven by the rising number of people suffering from chronic diseases.
Get the full scope of the report.
The covid-19 outbreak posed significant challenges for the healthcare sector across geographies. It impacted the growth of the chemiluminescence immunoassay (CLIA) analyzers market negatively as the imposition of lockdown affected product supply for a short period.
Here is the list of the group of customers that the Chemiluminescence immunoassay (CLIA) analyzers market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The chemiluminescence immunoassay analyzers market size is expected to witness an impressive growth of 5.8% CAGR in the coming years.
Siemens AG (Germany), bioMérieux SA (France), Abbott Laboratories (US), Johnson & Johnson (US), Tosoh Corporation (Japan), Randox Laboratories (UK), Ortho Clinical Diagnostics (US), Sysmex Corporation (Japan), DiaSorin (Italy), Beckman Coulter Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche AG (Switzerland) and Shenzhen New Industries Biomedical Engi-neering Co. Ltd (China) are among the key players in the chemiluminescence immunoassay analyzers market.
The chemiluminescence immunoassay analyzers market size is expected to reach USD 7.2 billion in the foreseeable future.
The hospitals & clinics segment is expected to register significant growth in the chemiluminescence immunoassay analyzers market in the coming years.
North America accounted for the largest share in the chemiluminescence immunoassay analyzers market in 2020.
Chemiluminescence immunoassay (CLIA) analyzers manufacturers, Chemiluminescence immunoassay (CLIA) analyzers suppliers, Chemiluminescence immunoassay (CLIA) analyzers distributors, Organizations, Government bodies are the target audience in the chemiluminescence immunoassay analyzers market.
WE ACCEPT
